Skip Navigation


Issue No. 50 | November 18, 2011
A Service of the U.S. Department of Health and Human ServicesView HTML version
News and Features 

Erratum Issued for Table 15b in the HHS Adult and Adolescent Antiretroviral Treatment Guidelines

Table 15b in the October 14, 2011, edition of the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents was recently updated to modify dosing recommendations and clinical comments for posaconazole and voriconazole when used in combination with efavirenz. The updated information is now available in PDF and HTML formats.

Redesigned AIDSinfo and infoSIDA Web Sites Coming Soon!

Change is coming to the AIDSinfo and infoSIDA Web sites! In commemoration of World AIDS Day, we will soon be unveiling redesigned AIDSinfo and infoSIDA Web sites. The redesign was driven by extensive user evaluation research and feedback. The Web sites have been reorganized to meet the needs of our users and to update the functionality and appearance of the two sites. In addition, infoSIDA, the Spanish-language sister site to AIDSinfo, will have its own Web address—

Stay tuned to future issues of At-a-Glance and our Facebook and Twitter pages for more information about the redesigned Web sites!

AIDSinfo Health Education Materials Include Fact Sheets on HIV and Its Treatment

HIV and Its Treatment is a series of easy-to-understand fact sheets intended for people living with HIV and their family members and friends. We recently reviewed the series to ensure that the information provided reflects the latest updates to the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera), a new fixed-dose combination medication, was added to the fact sheet that lists FDA-approved antiretroviral medications.

The fact sheets are available on the AIDSinfo Web site in printer-friendly formats. To order the HIV and Its Treatment fact sheet series, contact the AIDSinfo call center by e-mail (, phone (800-448-0440), or Live Chat.

Home | Guidelines | Clinical Trials | Drugs | Health Topics | Education Materials | Mobile Resources & Tools
Contact Us
Left footer corner image Left footer corner image